Chapter 6. Implementing Evidence-Based Medicine in Cardiology

  1. Salim Yusuf DPhil, FRCPC, FRSC Research Chair Professor of Medicine Director Vice President Research3,4,5,
  2. John A Cairns MD, FRCPC Professor of Medicine Former Dean6,
  3. A John Camm MD British Heart Foundation Professor Head of Cardiac7,
  4. Ernest L Fallen MD, FRCPC Professor Emeritus8 and
  5. Bernard J Gersh MB, ChB, DPhil Consultant Professor of Medicine9
  1. Brahmajee K Nallamothu MD, MPH, FACC Associate Professor1,
  2. Thomas T Tsai MD, MSc Fellow1 and
  3. Jack V Tu MD, PhD2

Published Online: 21 MAY 2010

DOI: 10.1002/9781444309768.ch6

Evidence-Based Cardiology, Third Edition

Evidence-Based Cardiology, Third Edition

How to Cite

Nallamothu, B. K., Tsai, T. T. and Tu, J. V. (2009) Implementing Evidence-Based Medicine in Cardiology, in Evidence-Based Cardiology, Third Edition (eds S. Yusuf, J. A. Cairns, A. J. Camm, E. L. Fallen and B. J. Gersh), Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781444309768.ch6

Editor Information

  1. 3

    McMaster University, Canada

  2. 4

    Population Health Research Institute, McMaster University, Hamilton Health Sciences, Canada

  3. 5

    Hamilton Health Sciences, Hamilton, Ontario, Canada

  4. 6

    Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada

  5. 7

    St George's University of London, London, UK

  6. 8

    McMaster University Faculty of Health Sciences, Hamilton, Ontario, Canada

  7. 9

    Mayo Clinic College of Medicine, Rochester, MN, USA

Author Information

  1. 1

    University of Michigan, Ann Arbor, MI, USA

  2. 2

    Schulich Heart Program, Sunnybrook Health Sciences Center, Toronto, Canada

Publication History

  1. Published Online: 21 MAY 2010
  2. Published Print: 13 NOV 2009

ISBN Information

Print ISBN: 9781405159258

Online ISBN: 9781444309768



  • evidence-based medicine implementation - cardiology;
  • reducing risk of death - aspirin, beta-blockers, ACE inhibitors, statins;
  • improvements in quality of life - ACE inhibitors, angiotensin receptor and aldosterone blockers;
  • practice gaps - scope of the problem;
  • adoption of behaviors - challenging;
  • framework for categorizing strategies - target level of care in healthcare system


This chapter contains sections titled:

  • Introduction

  • Practice gaps, knowledge translation and quality improvement science

  • Practice gaps: scope of the problem

  • Barriers to knowledge translation

  • Strategies for quality improvement

  • Future directions

  • Conclusion

  • References